{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Acurx Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"ACXP"},"Address":{"label":"Address","value":"259 LIBERTY AVENUE, STATEN ISLAND, New York, 10305, United States"},"Phone":{"label":"Phone","value":"+1 917 533-1469"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration."},"CompanyUrl":{"label":"Company Url","value":"https://www.acurxpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}